dihydro-7-hydroxy Mitragynine (inactive)
|
dihydro-7-hydroxy Mitragynine
(αE,2S,3S,7aS,12aR,12bS)-3-ethyl-1,2,3,4,6,7,7a,12,12a,12b-decahydro-7a-hydroxy-8-methoxy-α-(methoxymethylene)-indolo[2,3-a]quinolizine-2-acetic acid methyl ester MGM-15 |
|
| (E)-methyl 2-((2S,3S,7aS,12aR,12bS)-3-ethyl-7a-hydroxy-8-methoxy-1,2,3,4,6,7,7a,12,12a,12b-decahydroindolo[2,3-a]quinolizin-2-yl)-3-methoxyacrylate | |
| Other substances | |
| Synthetic opioids |
|
| 1158901-38-2 | |
|
|
InChI=1S/C23H32N2O5/c1-5-14-12-25-10-9-23(27)20-17(7-6-8-19(20)29-3)24-21(23)18(25)11-15(14)16(13-28-2)22(26)30-4/h6-8,13-15,18,21,24,27H,5,9-12H2,1-4H3/b16-13+/t14-,15+,18+,21-,23+/m1/s1
|
|
QXFXDJATKPXTFF-LIMHOZKTSA-N
|
|
|
C(C)[C@@H]1CN2CC[C@]3([C@@H]([C@@H]2C[C@@H]1/C(/C(=O)OC)=C\OC)NC1=CC=CC(=C13)OC)O
|
|
| C23H32N2O5 | |
| 416.5106 g/mol | |
|
, , , et al., “ From Kratom to Semi-Synthetic Opioids: The Rise and Risks of MGM-15,” Drug Testing and Analysis (2025): 1–6, https://doi.org/10.1002/dta.3952.
|